Zydus Lifesciences

The drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ

While the company's bottom line grew 10.5% annually over the 2016-17 through 2021-22 (FY22) period, it is expected to register thrice that growth rate over next two years, observes ICICI Securities

Company says operational performance came amid geopolitical turmoil resulting in supply chain challenges and inflationary pressures

The company had posted a consolidated net profit of Rs 679 crore in the same quarter of previous fiscal year, Zydus Lifesciences said in a regulatory filing.

Domestically produced variant-proof jabs are part of a global project to develop vaccines for future epidemics

Uncontrolled LDL-c, which poses a major risk of cardiovascular diseases, lacked proper treatment despite patients' lifestyle changes and use of statins

A senior government official had told Business Standard last week that so far there was no scientific evidence to expand the vaccination programme to young children

With this, vaccine will now be administered on day 0 and day 28. Earlier, it was approved as a triple dose on day 0, day 28 and day 56

Zydus to conduct mixing trials to test vax efficacy after two shots of Covishield/Covaxin

Zydus Lifesciences on Thursday said the US health regulator has issued three observations after inspecting its Jarod (Vadodara) based manufacturing facility.